Aralez Pharmaceuticals is a specialty pharmaceutical company that develops products primarily in the cardiovascular disease, pain, and other specialty areas. The company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Aralez Pharmaceuticals was incorporated in 2015 and is headquartered in Mississauga, Canada. It also has global headquarters in Princeton, New Jersey and Dublin, Ireland.